| Company Name: | Biomet, Incorporated | | Ticker Symbol: | BMET | | | WWW Address: | www.biomet.com |
| CEO: | Jeffrey R. Binder | | No. of Employees: | 4,254 |
| Common Issue Type: | CS | | Business Description: | The Company and its subsidiaries design, manufacture and market products used by musculoskeletal medical specialists in both surgical and non-surgical therapy.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | | | | 46.00 | 45.90 | |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 0.0 | 245.8 | 0.22 | 1.37 | 0.30 | 33.6 | 0.0 | 46.00 - 32.01 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 45.99 | $ | | PE Ratio - LTM | 33.6 | |
| Market Capitalisation | 0.0 | mil |
| Latest Shares Outstanding | 245.8 | mil |
| Earnings pS (EPS) | 1.37 | $ |
| Dividend pS (DPS) | 0.30 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 22 | % |
| Revenue per Employee | 495,399 | $ |
| Effective Tax Rate | 33.0 | % |
| Float | 235.5 | mil |
| Float as % of Shares Outstanding | 95.8 | % |
| Foreign Sales | 801 | mil |
| Domestic Sales | 1,306 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 4.50 | % |
| Gross Profit Margin | 74.1 | % |
| EBITDA Margin | 27.8 | % |
| Pre-Tax Profit Margin | 23.8 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 13.7 | % |
| Return on Equity (ROE) | 16.4 | % |
| Return on Capital Invested (ROCI) | 16.4 | % |
| Current Ratio | 4.2 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 54.7 | |
| Total Debt/Equity (Gearing Ratio) | 0.04 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 4.50 | $ |
| Cash pS | 0.93 | $ |
| Book-Value pS | 8.34 | $ |
| Tangible Book-Value pS | 6.21 | $ |
| Cash Flow pS | 1.76 | $ |
| Free Cash Flow pS | 0.91 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 5.51 | |
| Price/Tangible Book Ratio | 7.41 | |
| Price/Cash Flow | 26.1 | |
| Price/Free Cash Flow | 50.5 | |
| P/E as % of Industry Group | 121.0 | % |
| P/E as % of Sector Segment | 92.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.5 |
| Payout Ratio | 22.0 |
| 5-Y Average Payout Ratio | 15.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.2 | 100 | 3,666 | 12,862 |
| 4 Weeks | 46.00 | 45.75 | 45.83 | 0.3 | 97 | 4,385 | 74,541 |
| 13 Weeks | 46.00 | 45.24 | 45.72 | 0.6 | 99 | 10,752 | 655,844 |
| 26 Weeks | 46.00 | 42.41 | 42.49 | 8.2 | 101 | 17,997 | 2,231,681 |
| 52 Weeks | 46.00 | 32.01 | 32.19 | 42.9 | 125 | 21,062 | 5,223,316 |
| YTD | 46.00 | 41.17 | - | 11.4 | 104 | 20,619 | 3,814,458 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 45.95 | 45.93 | 45.67 | 44.35 | 43.73 | 0.22 | 0.83 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 12.51 | 96.2 | 9.11 |
| Income | 10.43 | 75.6 | 4.01 |
| Dividend | 29.53 | 98.1 | 25.89 |
| Capital Spending | 16.73 | NA | -33.36 |
| R&D | 14.02 | NA | 12.61 |
| Normalized Inc. | 10.73 | NA | 3.27 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 4.0 | 1.8 | 4.0 |
| Earnings % | -17.3 | -57.9 | -17.3 |
| EPS % | -16.0 | -57.5 | -16.0 |
| EPS $ | -0.26 | -0.23 | -0.26 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 45.00 |
| Current Ratio | 4.2 |
| Quick Ratio (Acid Test) | 2.1 |
| Liquidity Ratio (Cash) | 0.67 |
| Receivables Turnover | 4.2 |
| Average Collection Period | 86 |
| Working Capital/Equity | 54.0 |
| Working Capital pS | 4.50 |
| Cash-Flow pS | 1.76 |
| Free Cash-Flow pS | 0.91 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 18.96 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 16.6 |
| Total Debt/Equity (Gearing Ratio) | 0.04 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 3.1 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 54.7 |
| Interest/Capital Invested | 0.44 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 9.13 |
| Tobin's Q Ratio | 4.60 |
| Current P/E Ratio - LTM | 33.60 |
| Enterprise Value (EV)/EBITDA | 19.58 |
| Enterprise Value (EV)/Free Cash Flow | 58.93 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 7.41 |
| Price/Book Ratio - LTM | 5.51 |
| Price/Cash Flow Ratio | 26.1 |
| Price/Free Cash Flow Ratio - LTM | 50.5 |
| Price/Sales Ratio | 5.37 |
| P/E Ratio (1 month ago) - LTM | 33.4 |
| P/E Ratio (26 weeks ago) - LTM | 25.3 |
| P/E Ratio (52 weeks ago) - LTM | 19.7 |
| 5-Y High P/E Ratio | 36.0 |
| 5-Y Low P/E Ratio | 19.8 |
| 5-Y Average P/E Ratio | 27.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 122 |
| P/E as % of Industry Group | 121.0 |
| P/E as % of Sector Segment | 92.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 33.6 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.41 |
| Tangible Book Value pS - LTM | 6.21 |
| Book Value pS - LTM | 8.34 |
| Capital Invested pS | 8.34 |
| Cash pS - LTM | 0.93 |
| Cash Flow pS - LTM | 1.76 |
| Free Cash Flow pS - LTM | 0.91 |
| Earnings pS (EPS) | 1.37 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 10.61 |
| Free Cash Flow Margin 5YEAR AVG | 7.43 |
| Net Profit Margin | 15.9 |
| Net Profit Margin - 5YEAR AVRG. | 18.9 |
| Equity Productivity | 1.03 |
| Return on Equity (ROE) | 16.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 21.2 |
| Capital Invested Productivity | 1.03 |
| Return on Capital Invested (ROCI) | 16.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 21.2 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 13.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 16.6 |
| Gross Profit Margin | 74.1 |
| Gross Profit Margin - 5YEAR AVRG. | 74.8 |
| EBITDA Margin - LTM | 27.8 |
| EBIT Margin - LTM | 24.2 |
| Pre-Tax Profit Margin | 23.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 29.1 |
| Effective Tax Rate | 33.0 |
| Effective Tax Rate - 5YEAR AVRG. | 34.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 440 |
| Revenue per Employee | 495,399 |
| Net Income per Employee | 78,959 |
| Average Collection Period | 85 |
| Receivables Turnover | 4.2 |
| Day's Inventory Turnover Ratio | 355 |
| Inventory Turnover | 1.0 |
| Inventory/Sales | 25.6 |
| Accounts Payble/Sales | 3.26 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 1.91 |
| Fixed Assets Turnover | 2.09 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 9.22 |
| Revenue per $ Plant | 4.93 |
| Revenue per $ Common Equity | 1.03 |
| Revenue per $ Capital Invested | 1.03 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 37.9 |
| Research & Devlopment (R&D) as % of Revenue | 4.5 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 4.5 |
|
|  
|
| |
 |  |
